Neuralstem Appoints Ken Carter, Ph.D., as Executive Chairman of the Board

GERMANTOWN, Md., Dec. 18 (Korea Bizwire) — Neuralstem, Inc. (Nasdaq: CUR), a biopharmaceutical company focused on the development of nervous system therapies based on its neural stem cell and small molecule technologies, appointed Kenneth C. Carter, Ph.D., as the Company’s Executive Chairman of the Board to be effective on January 1, 2019. Dr. Carter will [...]